Cargando…
miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner
BACKGROUND: Gastric cancer (GC) is a common malignant disease worldwide. Aberrant miRNAs expression contributes to malignant cells behaviour, and in preclinical research, miRNA targeting has shown potential for improving GC therapy. Our present study demonstrated that miR-632 promotes GC progression...
Autores principales: | Shi, Ying, Huang, Xiaoxiao, Chen, Guobin, Wang, Ying, Liu, Yuansheng, Xu, Wei, Tang, Shaohui, Guleng, Bayasi, Liu, Jingjing, Ren, Jianlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322242/ https://www.ncbi.nlm.nih.gov/pubmed/30612555 http://dx.doi.org/10.1186/s12885-018-5247-z |
Ejemplares similares
-
Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers
por: Xiao, Li, et al.
Publicado: (2014) -
Trefoil factor family 2 expression inhibits gastric cancer cell growth and invasion in vitro via interactions with the transcription factor Sp3
por: Cai, Yiling, et al.
Publicado: (2016) -
Association between Promoter Polymorphisms of TFF1, TFF2, and TFF3 and the Risk of Gastric and Diffuse Gastric Cancers in a Korean Population
por: Jin, Eun-Heui, et al.
Publicado: (2015) -
Validation of the DNA Methylation Landscape of TFF1/TFF2 in Gastric Cancer
por: Qian, Ze, et al.
Publicado: (2022) -
Pyruvate Kinase M2 Plays a Dual Role on Regulation of the EGF/EGFR Signaling via E-Cadherin-Dependent Manner in Gastric Cancer Cells
por: Wang, Le-Yi, et al.
Publicado: (2013)